Pharma & Biotech

Gilead Sciences finds itself at a critical investment juncture as conflicting developments within its pharmaceutical pipeline create uncertainty for shareholders....

Investors in Arrowhead Pharmaceuticals are bracing for significant volatility as the biotechnology firm approaches two major regulatory events that could...

Intellia Therapeutics shares experienced a severe downturn on Friday, plummeting 22.7% as investors reacted to a devastating combination of clinical,...

The biotechnology firm Ocugen finds itself in a pivotal position, balancing promising clinical progress against a rapidly diminishing cash reserve....

Danish pharmaceutical giant Novo Nordisk finds itself navigating turbulent waters following a significant pricing agreement with US authorities and an...

In a landmark corporate acquisition, pharmaceutical titan Pfizer has successfully outmaneuvered competitor Novo Nordisk, securing the prized drug developer Metsera...

Nautilus Biotechnology is showing tangible progress on multiple fronts, according to its latest quarterly results. The company's third-quarter report reveals...

Eli Lilly's ambitious push into artificial intelligence is generating significant excitement across Wall Street. The pharmaceutical giant's recent alliance with...

The financial outlook for Ocugen has grown increasingly precarious, with the biotechnology firm's stock extending losses for five consecutive trading...

Corcept Therapeutics shares have experienced significant volatility in recent trading sessions, creating both concern and opportunity for investors. The biopharmaceutical...